SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8:1-96.
  • 2
    Prendes JL. Considerations on the use of propanolol in complicated migraine. Headache: The Journal of Head and Face Pain. 1980;20:93-95.
  • 3
    Gilbert GJ. An occurrence of complicated migraine during propanolol therapy. Headache: The Journal of Head and Face Pain. 1982;22:81-83.
  • 4
    Bardwell A & Trott JA. Stroke in migraine as a consequence of propanolol. Headache: The Journal of Head and Face Pain. 1987;27:381-383.
  • 5
    Mendizabal JE, Greiner F, Hamilton WJ, Rothrock JF. Migrainous stroke causing thalamic infarction and amnesia during treatment with propanolol. Headache: The Journal of Head and Face Pain. 1997;37:594-596.
  • 6
    Massiou H & Bousser MG. Bêta-bloquants et migraine. Path Biol. 1992;40:373-380.
  • 7
    Olesen J. Beta adrenergic effects on cerebral circulation. Cephalalgia. 1989;9:287-291.
  • 8
    Joseph R, Steiner TJ, Schultz LU, Clifford RF. Platelet activity and selective beta-blockade in migraine prophylaxis. Stroke. 1988;19:704-708.
  • 9
    Hansen AJ, Lauritzen M, Tfelt HP. Spreading cortical depression and antimigraine drugs. In: AmeryWK, Van NuetenJM, WauquierA, eds. The Pharmacological Basis of Migraine Therapy. Bath: Pitman;1984:161-174.